Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,763 | 6,361 | 8,921 | 7,474 | 7,052 |
| Receivables | 97 | 51 | N/A | 129 | N/A |
| TOTAL | $5,983 | $6,580 | $9,109 | $7,709 | $7,158 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $5,983 | $6,580 | $9,109 | $7,709 | $7,158 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,319 | 3,153 | 3,110 | 3,042 | 3,223 |
| TOTAL | $3,319 | $3,153 | $3,110 | $3,042 | $3,223 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,319 | $3,153 | $3,110 | $3,042 | $3,223 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 845 | 812 | 792 | 788 | 688 |
| Common Shares | 17 | 16 | 16 | 15 | 13 |
| Retained earnings | -64,540 | -61,719 | -57,597 | -53,219 | -48,104 |
| TOTAL | $2,664 | $3,428 | $5,999 | $4,667 | $3,935 |
| Total Liabilities And Equity | $5,983 | $6,580 | $9,109 | $7,709 | $7,158 |